AdvaUD Tablet 15's

AdvaUD Tablet 15's is used to treat primary biliary cholangitis (a liver autoimmune disease), cholestatic liver problems, fatty liver disease, liver inflammation in cystic fibrosis sufferers, and gallstones. It improves bile flow, decreases liver inflammation, and lowers the risk of liver damage.

AdvaUD Tablet 15's contains Nor-Ursodeoxycholic Acid, which works by improving bile flow through the liver and bile ducts. It produces a special “bicarbonate-rich” bile that protects the ducts from irritation, reduces inflammation, and helps prevent further damage. Nor-UDCA also reduces harmful bile acids, supports liver cell recovery, and may slow the progression of liver scarring (fibrosis). Together, these actions help relieve cholestasis and protect the liver over time.

AdvaUD Tablet 15's may cause common side effects such as abdominal pain, diarrhoea, nausea, and dizziness. Most of these side effects do not require medical attention and will resolve gradually over time. However, consult your doctor if any of these side effects persist.

Do not take AdvaUD Tablet 15's if you are allergic to any of its components. Consult your doctor if you are pregnant or breastfeeding. Keep your doctor informed about your health condition and any medications you are taking to rule out any potential interactions.

AdvaUD Tablet 15's is used to treat primary biliary cholangitis (a liver autoimmune disease), cholestatic liver problems, and fatty liver disease. The detailed uses of AdvaUD Tablet 15's are as follows:

• Treatment of Cholestatic Liver Disorders: Nor-UDCA is used to increase bile flow and reduce inflammation in conditions where bile flow is inadequate. It is very effective in bile duct disorders.
• Supportive Treatment for Primary Sclerosing Cholangitis (PSC): It may reduce bile duct injury, improve liver tests, and halt disease development in PSC.
• Add-On Therapy for Primary Biliary Cholangitis (PBC): If bile flow remains inadequate, doctors may add Nor-UDCA to standard treatment.
• Treatment of Liver Inflammation and Early Fibrosis: It may help minimise scarring and inflammation in certain chronic liver disorders.
• Investigational Use for Fatty Liver Disease (NAFLD/NASH): According to research, there may be benefits to lowering liver enzymes and reducing inflammation.
• Gallstone Management: It helps dissolve gallstones, especially cholesterol gallstones.

• AdvaUD Tablet 15's can be taken with food to prevent stomach upset or as advised by the doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Swallow AdvaUD Tablet 15's as a whole with a glass of water.
• Do not chew, crush, or break it.

• AdvaUD Tablet 15's protects liver cells from injury caused by toxic bile acids and improves liver function.
• It is an effective therapy for primary biliary cirrhosis (a chronic autoimmune liver disease), by slowing its progression and improving overall liver function.
• AdvaUD Tablet 15's helps manage associated liver disease. It improves liver function and helps clear obstructions in the bile ducts.
• This medicine can relieve symptoms of bile reflux gastritis, a condition in which bile flows backwards into the stomach and oesophagus, causing irritation.

• Do not take AdvaUD Tablet 15's if you are allergic to any of its contents.
• Also, avoid taking AdvaUD Tablet 15's if you have inflammation of the gallbladder and bile ducts, narrowing or blockage of bile ducts, biliary colic, calcified gallstones, improper constriction of the gallbladder, gastric or duodenal ulcer.
• Inform your doctor before taking AdvaUD Tablet 15's if you have variceal bleeding (high blood pressure in portal veins), ascites (excess abdominal fluid), liver encephalopathy or liver disease.
• Consult your doctor if you are pregnant or breastfeeding.
• Tell your doctor if you are taking, have recently taken or might take any other medicines to prevent any potential interactions.